Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

425 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The beta 2-agonist controversy. Observations, explanations and relationship to asthma epidemiology.
Sears MR, Taylor DR. Sears MR, et al. Among authors: taylor dr. Drug Saf. 1994 Oct;11(4):259-83. doi: 10.2165/00002018-199411040-00005. Drug Saf. 1994. PMID: 7848546 Review.
Polymorphism of the beta2-adrenoceptor and the response to long-term beta2-agonist therapy in asthma.
Hancox RJ, Sears MR, Taylor DR. Hancox RJ, et al. Among authors: taylor dr. Eur Respir J. 1998 Mar;11(3):589-93. Eur Respir J. 1998. PMID: 9596107 Clinical Trial.
The beta-agonist controversy.
Taylor DR, Sears MR, Cockcroft DW. Taylor DR, et al. Med Clin North Am. 1996 Jul;80(4):719-48. doi: 10.1016/s0025-7125(05)70465-x. Med Clin North Am. 1996. PMID: 8676612 Review.
Interaction between corticosteroid and beta-agonist drugs. Biochemical and cardiovascular effects in normal subjects.
Taylor DR, Wilkins GT, Herbison GP, Flannery EM. Taylor DR, et al. Chest. 1992 Aug;102(2):519-24. doi: 10.1378/chest.102.2.519. Chest. 1992. PMID: 1353717 Clinical Trial.
Genetic variation of the beta(2)-adrenoceptor: its functional and clinical importance in bronchial asthma.
Taylor DR, Kennedy MA. Taylor DR, et al. Am J Pharmacogenomics. 2001;1(3):165-74. doi: 10.2165/00129785-200101030-00002. Am J Pharmacogenomics. 2001. PMID: 12083965 Review.
Relationship between socioeconomic status and asthma: a longitudinal cohort study.
Hancox RJ, Milne BJ, Taylor DR, Greene JM, Cowan JO, Flannery EM, Herbison GP, McLachlan CR, Poulton R, Sears MR. Hancox RJ, et al. Among authors: taylor dr. Thorax. 2004 May;59(5):376-80. doi: 10.1136/thx.2003.010363. Thorax. 2004. PMID: 15115861 Free PMC article.
Randomised trial of an inhaled beta2 agonist, inhaled corticosteroid and their combination in the treatment of asthma.
Hancox RJ, Cowan JO, Flannery EM, Herbison GP, McLachlan CR, Wong CS, Taylor DR. Hancox RJ, et al. Among authors: taylor dr. Thorax. 1999 Jun;54(6):482-7. doi: 10.1136/thx.54.6.482. Thorax. 1999. PMID: 10335000 Free PMC article. Clinical Trial.
Long-acting beta-agonist treatment in patients with persistent asthma already receiving inhaled corticosteroids.
Hancox RJ, Taylor DR. Hancox RJ, et al. Among authors: taylor dr. BioDrugs. 2001;15(1):11-24. doi: 10.2165/00063030-200115010-00002. BioDrugs. 2001. PMID: 11437672 Review.
Asthma exacerbations during long term beta agonist use: influence of beta(2) adrenoceptor polymorphism.
Taylor DR, Drazen JM, Herbison GP, Yandava CN, Hancox RJ, Town GI. Taylor DR, et al. Thorax. 2000 Sep;55(9):762-7. doi: 10.1136/thorax.55.9.762. Thorax. 2000. PMID: 10950895 Free PMC article. Clinical Trial.
Effects of inhaled beta agonist and corticosteroid treatment on nuclear transcription factors in bronchial mucosa in asthma.
Hancox RJ, Stevens DA, Adcock IM, Barnes PJ, Taylor DR. Hancox RJ, et al. Among authors: taylor dr. Thorax. 1999 Jun;54(6):488-92. doi: 10.1136/thx.54.6.488. Thorax. 1999. PMID: 10335001 Free PMC article. Clinical Trial.
425 results
Jump to page
Feedback